Correction to: 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of diabetes (EASD) (Diabetologia, (2020), 63, 2, (221-228), 10.1007/s00125-019-05039-w)

Geltrude Mingrone, John B. Buse, Deborah J. Wexler, Apostolos Tsapas, Peter Rossing, Chantal Mathieu, David A. D’Alessio, Melanie J. Davies

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

The incorrect figure legend was printed for Fig. 2. The correct legend should have read ‘Choosing glucose-lowering medication in those with indicators of high-risk or established atherosclerotic cardiovascular disease (ASCVD), chronic kidney disease (CKD) or heart failure (HF)’, as per the figure heading.
Lingua originaleEnglish
pagine (da-a)1667-1667
Numero di pagine1
RivistaDiabetologia
Volume63
DOI
Stato di pubblicazionePubblicato - 2020

Keywords

  • HYPERGLYCAEMIA

Fingerprint

Entra nei temi di ricerca di 'Correction to: 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of diabetes (EASD) (Diabetologia, (2020), 63, 2, (221-228), 10.1007/s00125-019-05039-w)'. Insieme formano una fingerprint unica.

Cita questo